Stress and IGF-I Differentially Control Cell Fate Through Mammalian Target of Rapamycin (mTOR) and Retinoblastoma Protein (pRB)

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m805724200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
2010English

Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases

Biomedical Journal
Medicine
2013English

TGFβ- And Bleomycin-Induced Extracellular Matrix Synthesis Is Mediated Through Akt and Mammalian Target of Rapamycin (mTOR)

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2011English

Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids

European Oncology and Haematology
OncologyHematology
2015English

Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Mammalian Target of Rapamycin (mTOR) Complex 2 Regulates Filamin A-Dependent Focal Adhesion Dynamics and Cell Migration

Genes to Cells
MedicineGeneticsCell Biology
2016English

The Mammalian Target of Rapamycin Protein Expression in Human Granulosa Cell Tumors

Journal of the Turkish German Gynecology Association
GynecologyObstetrics
2019English

Control of Retinoblastoma Protein-Independent Hematopoietic Cell Cycle by the pRB-related P130

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy